Search results for: Health Policy and Regulation
Filter search results
2014 Annual Lecture: Is Universal Health Care Coverage the Holy Grail?
7 May 2014
…such as DFID, the Wellcome Trust, EU and WHO, and as the Head of the Faculty of Public Health and Policy. She has advised many multilateral, bilateral and government agencies;…
OHE Academy
What is health economics? Health Economics explores how we allocate resources to improve health and deliver care efficiently, equitably, and sustainably. It helps decision-makers answer critical questions: What works? For…
The true cost and burden of frontotemporal dementia: Early insights into a pressing challenge
22 September 2025
…validation of novel biomarkers and the development of AI-driven diagnostic tools. The consortium brings together experts and institutions from Finland, Germany, Italy, Lithuania, Luxembourg, the Netherlands, Spain, and the United…
A New Way of Presenting Health States in Valuation Studies
18 January 2018
…L. and Ibbotson, R., 2016. Valuing health using time trade-off and discrete choice experiment methods: does dimension order impact on health state values? Value in Health, 19, pp.210-217. DOI: 10.1016/j.jval.2015.11.005…
2015 OHE Annual Lecture: Regulation, Reimbursement, and Evidence on New Medical Technologies: Experiences and Future Directions in the United States
10 June 2015
…McClellan, MD, PhD, is a Senior Fellow and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. His work focuses on strategies and policy…
Lung Cancer’s Biggest Test: How Can We Mobilise NGS Testing to Transform Lung Cancer Care?
7 December 2023, 12:00am
…to the World Health Organization. He has been President of the International Society for Pharmacoeconomics and Outcomes Research and is currently Co-Editor-in-Chief of Value in Health. Professor Alastair Greystoke |…
A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”
1 May 2018
…and the removal of patent protection in the context of on-patent drugs. However, in many markets some recovery of R&D cost is both to be expected and is necessary. Health…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
…It builds on work undertaken with Kalipso Chalkidou, Rachel Silverman and Ganesh Ramakrishnan from the Center for Global Development, and Hannah Kettler from PATH, and with Martina Garau and Marina…
Adaptation to Health States: Sick Yet Better Off?
21 June 2017
…However, controversy remains on the methodological underpinning of how health outcome measurements are obtained. For instance, health technology assessment in England by the National Institute of Health and Care Excellence…